162 related articles for article (PubMed ID: 26831719)
21. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis.
Sloothaak DA; Sahami S; van der Zaag-Loonen HJ; van der Zaag ES; Tanis PJ; Bemelman WA; Buskens CJ
Eur J Surg Oncol; 2014 Mar; 40(3):263-9. PubMed ID: 24368050
[TBL] [Abstract][Full Text] [Related]
23. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging.
Piva MG; Navaglia F; Basso D; Fogar P; Roveroni G; Gallo N; Zambon CF; Pedrazzoli S; Plebani M
Oncology; 2000 Nov; 59(4):323-8. PubMed ID: 11096345
[TBL] [Abstract][Full Text] [Related]
24. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
25. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma.
Kijima F; Natsugoe S; Takao S; Aridome K; Baba M; Yoshifumi M; Eizuru Y; Aikou T
Oncology; 2000; 58(1):38-44. PubMed ID: 10644939
[TBL] [Abstract][Full Text] [Related]
26. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
[TBL] [Abstract][Full Text] [Related]
27. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
[TBL] [Abstract][Full Text] [Related]
28. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
29. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer.
Hara M; Nakanishi H; Jun Q; Kanemitsu Y; Ito S; Mochizuki Y; Yamamura Y; Kodera Y; Tatematsu M; Hirai T; Kato T
Clin Exp Metastasis; 2007; 24(3):179-89. PubMed ID: 17487561
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
32. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.
Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
Int J Cancer; 2004 Jan; 108(3):412-7. PubMed ID: 14648708
[TBL] [Abstract][Full Text] [Related]
33. Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Nishimura Y; Katoh H; Yamashita K; Watanabe M; Yamaguchi K
J Gastrointest Surg; 2017 May; 21(5):867-878. PubMed ID: 28251467
[TBL] [Abstract][Full Text] [Related]
34. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
[TBL] [Abstract][Full Text] [Related]
35. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis.
Rahbari NN; Bork U; Motschall E; Thorlund K; Büchler MW; Koch M; Weitz J
J Clin Oncol; 2012 Jan; 30(1):60-70. PubMed ID: 22124103
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients.
Godfrey TE; Raja S; Finkelstein SD; Gooding WE; Kelly LA; Luketich JD
Clin Cancer Res; 2001 Dec; 7(12):4041-8. PubMed ID: 11751499
[TBL] [Abstract][Full Text] [Related]
37. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
[TBL] [Abstract][Full Text] [Related]
38. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
39. The expression of carcinoembryonic antigen mRNA in the lavage of the dissected area of the lateral lymph nodes influences the lateral recurrence of lower rectal cancer.
Takasu K; Hara M; Yanagita T; Nakai N; Ando N; Maeda Y; Hirokawa T; Shiga K; Matsuo Y; Takahashi H; Takiguchi S
Surg Today; 2022 Jan; 52(1):84-91. PubMed ID: 34617146
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer.
Bao F; Zhao LY; Balde AI; Liu H; Yan J; Li TT; Chen H; Li GX
Colorectal Dis; 2016 Sep; 18(9):O322-9. PubMed ID: 27438774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
